skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Intraperitoneal radiolabeled OC 125 in patients with advanced ovarian cancer

Journal Article · · Gynecologic Oncology; (USA)

Twenty patients with recurrent or persistent epithelial ovarian cancer failing conventional therapies were treated with a single intraperitoneal injection of iodine-131-labeled OC 125 monoclonal antibody. Rare acute side effects were nausea and mild diarrhea. At doses up to 120 mCi of iodine-131, median white blood cell and platelet count nadirs were 3.6k/microliters and 187k/microliters, respectively. Two patients acquired thyroid toxicities despite thyroid blockage with cold iodine. One patient had transient TSH elevation while remaining clinically euthyroid, and 1 patient developed activation of a thyroid nodule and clinical hyperthyroidism. Dose-limiting toxicity has not yet been observed. Twelve of 20 patients are alive 3 to 17 months following therapy. Tumor progression was noted in the majority of patients, although 3 patients had documented decreases in tumor burden of short duration. We conclude that, at the doses examined, iodine-131 OC 125 can be safely administered intraperitoneally.

OSTI ID:
5479479
Journal Information:
Gynecologic Oncology; (USA), Vol. 34:3; ISSN 0090-8258
Country of Publication:
United States
Language:
English

Similar Records

Human anti-murine antibody responses in ovarian cancer patients undergoing radioimmunotherapy with the murine monoclonal antibody OC-125
Journal Article · Wed Aug 01 00:00:00 EDT 1990 · Gynecologic Oncology; (USA) · OSTI ID:5479479

Distribution and pharmacokinetics of radiolabeled monoclonal antibody OC 125 after intravenous and intraperitoneal administration in gynecologic tumors
Journal Article · Sat Oct 01 00:00:00 EDT 1988 · Am. J. Obstet. Gynecol.; (United States) · OSTI ID:5479479

Antibody-guided irradiation of advanced ovarian cancer with intraperitoneal monoclonal antibodies
Journal Article · Tue Dec 01 00:00:00 EST 1987 · J. Clin. Oncol.; (United States) · OSTI ID:5479479